Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice. $VDRM should release some update news about this!
Very Insightful. Thank you, Scherzman.
VDRM SECURITY DETAILS
Share Structure
Market Cap Market Cap
8,556,941
10/26/2022
Authorized Shares
1,000,000,000
10/14/2022
Outstanding Shares
983,556,451
10/14/2022
Restricted
69,456,186
10/14/2022
Unrestricted
914,100,265
10/14/2022
Held at DTC
912,867,184
10/14/2022
Float
911,600,265
07/23/2021
Par Value
0.001
https://www.otcmarkets.com/stock/VDRM/security
WE’RE PLEASED TO ANNOUNCE THE APPOINTMENT OF A NEW SENIOR MANAGEMENT TEAM
Ontario, Calif., Oct. 18, 2022 — Kiwa Bio-Tech Products Group Corporation (OTCBB: KWBT). On October 18, the Board of Directors of the Company adopted a resolution to appoint a new management team.
According to the Restructuring Plan between the Company and Xiaoman Company, Xiaoman Company proposed candidates for the new senior management team. The Board of Directors of the Company held a meeting on October 18, 2022 and decided to appoint:
Ms. Ziqi Wang as Chief Executive Officer;
Mr. Sen Yang as Chief Financial Officer;
Mr. Boyu Liu as Chief Operation Officer;
Mr.Chaozhao Zhao as Executive President and General Manager of Mining Business Department;
Mr. Dadong Li as Executive Vice President;
Mr. Mingzheng Bao as Chief Administrative Officer and Chief Growth Officer;
Ms. Mei Dong as Director of International Investment and Finance;
Mr. Xuefeng Guo as Vice President.
The Company’s Chairman Mr. Wade Li states again that “this reorganization with the new senior management team is able to inject substantial support for development of the company, enhance the endogenous power and will bring the company to a new height of development.”
Forward-Looking Statements
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.
For investor and media inquiries, please contact:
Email: myli@kiwabiotech.com
Category: News Release
10/26/2022
https://kiwabiotech.com/were-pleased-to-announce-the-appointment-of-a-new-senior-management-team/
$BRQS, OS 18.65 Mil, Increasing revenue.
https://investorshub.advfn.com/Borqs-International-Holding-Corp-32490
$CABA @ $1.73, Target $10
Insiders buying.
https://investorshub.advfn.com/Cabaletta-Bio-Inc--CABA-40973
https://finance.yahoo.com/quote/CABA?p=CABA
$TAMG, Bokoo TV, Low float ~ 14.7 mil, OS - 136.8 Mil & Shell Badge just removed. Ready to soar!
https://www.otcmarkets.com/stock/TAMG/security
https://www.otcmarkets.com/stock/TAMG/profile
https://www.transnational-group.com/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170273612
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170274704
$TAMG
Awesome!
Not sure.
But no online buy order for ETrade.
Bring on 0.05+, Been holding some shares for 2 years+
Then, series of news finally come the next week and many many weeks after...
How high squeeze? 20-30 X+++ from previous ath?
Hmmm....
Thanks, Bountiful_Harvest.
$CABA @$1.85, Cabaletta Bio Inc . (CABA)
https://investorshub.advfn.com/Cabaletta-Bio-Inc--40973
https://finance.yahoo.com/quote/CABA?p=CABA
Insiders buying CABA
$CABA - CEO, CFO, President, Science and Technology, and 2 other directors bought shares yesterday. Then today, CEO loaded more shares. Awesome pipelines on autoimmune diseases like Lupus. Still near bottom. Heading back to $14.95 last November. @MoonMarket_ @theresa_perrin
— BIOTECH SCANNER (@BIOTECHSCANNER) October 20, 2022
$CABA @$1.30, Cabaletta Bio Inc . (CABA)
https://investorshub.advfn.com/Cabaletta-Bio-Inc--40973
https://finance.yahoo.com/quote/CABA?p=CABA
Insiders buying CABA
$CABA - CEO, CFO, President, Science and Technology, and 2 other directors bought shares yesterday. Then today, CEO loaded more shares. Awesome pipelines on autoimmune diseases like Lupus. Still near bottom. Heading back to $14.95 last November. @MoonMarket_ @theresa_perrin
— BIOTECH SCANNER (@BIOTECHSCANNER) October 20, 2022
$CABA - CEO, CFO, President, Science and Technology, and 2 other directors bought shares yesterday. Then today, CEO loaded more shares. Awesome pipelines on autoimmune diseases like Lupus. Still near bottom. Heading back to $14.95 last November. @MoonMarket_ @theresa_perrin
— BIOTECH SCANNER (@BIOTECHSCANNER) October 20, 2022
Very Nice find. EPMB is listed on Malaysian Stock Exchange, btw.
https://www.thestar.com.my/business/marketwatch/stocks/?qcounter=EPMB
Hope so. Thank you, Bountiful_Harvest.
DIGAF SECURITY DETAILS
Share Structure
Market Cap Market Cap
512,691
10/19/2022
Authorized Shares
Unlimited
10/12/2022
Outstanding Shares
1,708,969,288
10/12/2022
Restricted
10,673,449
10/12/2022
Unrestricted
1,698,295,839
10/12/2022
Held at DTC
1,698,228,377
10/12/2022
Float
368,513,533
11/05/2019
Par Value
No Par Value
https://www.otcmarkets.com/stock/DIGAF/security
$AVCT I am not the only one that sees this as NON dilutive. pic.twitter.com/UUAEx4EYlz
— Theresa Perrin (@theresa_perrin) October 19, 2022
Timing was not good.
Awesome
$CABA @ 0.9275 , Cabaletta Bio, Inc. (CABA)
https://investorshub.advfn.com/Cabaletta-Bio-Inc--CABA-40973
https://finance.yahoo.com/quote/CABA/key-statistics?p=CABA
https://finance.yahoo.com/quote/CABA?p=CABA
0.05+ Soon!
KWBT SECURITY DETAILS
Share Structure
Market Cap Market Cap
246,734
10/17/2022
Authorized Shares
3,000,000,000
10/17/2022
Outstanding Shares
616,834,501
10/17/2022
Restricted
42,664,165
10/17/2022
Unrestricted
574,170,336
10/17/2022
Held at DTC
572,328,044
10/17/2022
Float
265,529,491
05/29/2020
Par Value
Not Available
https://www.otcmarkets.com/stock/KWBT/security
BHPA SECURITY DETAILS
Share Structure
Market Cap Market Cap
4,993,298
10/17/2022
Authorized Shares
975,000,000
10/17/2022
Outstanding Shares
344,365,346
10/17/2022
Restricted
319,529,162
10/17/2022
Unrestricted
24,836,184
10/17/2022
Held at DTC
12,224,577
10/17/2022
Float
14,743,249
06/29/2021
Par Value
0.001
https://www.otcmarkets.com/stock/BHPA/security
Rumors?
Nice, 135k Revenue and Net Income.
3rd Quarter filing in 4 weeks?
Thanks, Bountiful_Harvest.
— Dodger (@realscottdodge) October 16, 2022